Johnson & Johnson (NYSE: JNJ) announced today that 43 presentations showcasing the Company's rheumatology pipeline and portfolio will be featured at the American College of Rheumatology (ACR) 2024 ...
Researchers explored the relationships between neighborhood-level environmental and social vulnerabilities and fragmented care among patients with rheumatic conditions.
Project IMPACT: Discovering the best way to manage autoimmune conditions Project IMPACT invites individuals undergoing treatment with specialty medications ... Inflammatory Diseases." By combining ...